GSK BHR Study (Sont - Second Study)

NCT01324362 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

446

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: FP 100mcg
DRUG: FP 250mcg
DRUG: FP 500mcg
DRUG: FSC 100/50mcg
DRUG: FSC 250/50mcg
DRUG: FSC500/50mcg

Sponsor

GlaxoSmithKline